PDF
Published
2023-12-31
Section
Articles
License
Copyright (c) 2024 THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY LICENSE http://creativecommons.org/licenses/by/4.0/
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Medical Journal of Tikrit University is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the MJTU website, while MJTU is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
Evaluation the Non enzymatic antioxidants in patients with β-thalassemia major among Iraqi patients
Aveen Loqman Juma
Biochemistry Department / Medicine College. Tikrit University, Tikrit, Iraq
Ammar Lateef Hussein
Biochemistry Department / Medicine College. Tikrit University, Tikrit, Iraq
Israa Hashim Saadoon
Microbiology Department/Collage of Medicine/ Tikrit University, Tikrit, Iraq
DOI: https://doi.org/10.25130/mjotu.29.1.4
Keywords: β-Thalassemia major, Coenzyme Q10, vitamin C, Vitamin E, uric acid.
Abstract
Background: β-thalassemia major (β-TM) is a major health problem in the world that forces patients to repeat blood transfusions. Frequent blood transfusions cause toxic iron overload. The association between serum iron levels and β-thalassemia major has been studied extensively in the literature. Several studies have evaluated the oxidant and antioxidant statuses of thalassemia patients. However, most studies have focused mainly on the enzymatic antioxidant and intermediate states and thus few data are available for non-enzymatic antioxidant like Coenzyme Q10.
aim of study: To evaluate the concentration of some non- enzymatic antioxidant measurements like Coenzyme Q10, Vitamin C, Vitamin E, uric acid, and bilirubin in the plasma of patients who suffered from beta – thalassemia major.
Patients and Methods: Case- control study designed includes 90 participating (60 β-TM patients and 30 subjects as control groups). The age range of patients and control group was (15 - 40 years). This study was conducted in Teaching Baghdad Hospital - Baghdad and Al-Karama Hospital during the period from December 2022 to March 2023.
Results: The mean of serum Coenzyme Q10 was (3.55 ± 1.62 and 2.02 ± 0.88 ng/ml) in β-TM patients and control group respectively. The results reveled that the mean of vitamin C was (6.85 ± 3.0 and 12.23 ± 2.99 ng/ml) in β-TM and control group respectively. Also, the results shows that the mean of Vitamin E was (2.29 ± 1.69 and 7.25 ± 2.79 ng/ml) in β-TM patients and control respectively. Also, the results reveled that mean of uric acid was (3.62 ± 1.34 and 3.86 ± 1.48 mg/dl) in β-TM patients and control group respectively. The level of bilirubin was (1.99 ± 1.25 and 0.65 ± 0.6 mg/dl) in patients and control group respectively. Also, the result shows there was a significant correlation between Coenzyme Q10 and Vitamin C ((r=0.280, p=0.030) and non-significant correlation between Coenzyme Q10 and Vitamin E (r=0.084, p=0.522).
Conclusion: This study shows there were lower antioxidant capacities as demonstrated by the results in patients with β-TM patients in comparison with control group.
